|
General scheme of the study |
|||||
| Phase A |
Phase B |
||||
|
|
|||||
| Randomisation |
|||||
| by cages |
![]() |
![]() |
|||
| within cages by treatments |
- |
![]() |
|||
|
|
|||||
| Blinding |
|||||
| Treatment administration |
- |
![]() |
|||
| Edema measurement |
![]() |
![]() |
|||
|
|
|||||
| Inflammation model |
CA |
BL |
CA |
||
|
|
|||||
| Homeopathic remedies |
|||||
| dilution |
n. of animals studied |
||||
|
|
|||||
| Arnica |
D4 |
71 |
O/I |
O/I |
- |
| Apis |
D4 |
90 |
O/I |
O/I |
O |
| Apis |
D30 |
18 |
- |
- |
O |
| Atropa |
D4 |
72 |
O/I |
O/I |
- |
| Hamamelis |
D4 |
72 |
O/I |
O/I |
- |
| Lachesis |
D6 |
86 |
O/I |
O/I |
O |
| Lachesis |
D30 |
18 |
- |
- |
O |
| Phosphorus |
D6 |
90 |
O/I |
O/I |
O |
| Phosphorus |
D30 |
18 |
- |
- |
O |
| Reference treatments |
|||||
| Placebo: |
|||||
| Physiological solution |
86 |
O/I |
O/I |
O |
|
| Active comparator: |
|||||
| Indomethacin |
88 |
I/I |
I/I |
I |
|
|
O = oral administration I = administration through injection CA = carrageenan induced edema BL = autologous blood induced edema Each treatment group has been tested through 3 replications. In each replication 6 rats were studied. In experiment A 11 rats were excluded from the analyses because of problems with edema induction. | |||||
Conforti et al. BMC Complementary and Alternative Medicine 2007 7:1 doi:10.1186/1472-6882-7-1 |
|||||